Likewise, coadministration of 4-1BB and OX40 antibodies resulted in synergistic effects in the proliferation and functions of CD8+ T cells, produced by the concurrent stimulation of two different receptors that modulate such anti-tumor immune responses in dichotomous, independent ways (92–94). Here, TNFRSF9 is linked to neoplasm.